Cardio Round-up: FOURIER Analysis, Alcohol AFib Risk; and More

Cardio Round-up: FOURIER Analysis, Alcohol AFib Risk; and More

In a landmark analysis of the FOURIER trial, the addition of the PCSK9 inhibitor evolocumab to moderate to intense statin therapy was associated with a reduced risk for complex coronary disease that would require complex...

Curated Journal reading List